{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "607.45",
    "chg": 24.75,
    "chgp": "4.25%",
    "dir": 1,
    "prev_price": "582.70",
    "mcapval": "5,598.42 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE939A01011",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "2.17 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/1",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Science Outperforms Sector Amid Broader Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-gains-6-57-marks-fourth-consecutive-day-of-increases-1693482",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/StridesPharmaSc_priceRelatedfactors_883381.png",
        "date": "2025-04-03 09:35:20",
        "description": "Strides Pharma Science has demonstrated strong performance, gaining 6.57% on April 3, 2025, and outperforming its sector. The stock has shown a notable upward trend over the past four days, with a significant annual increase of 78.60%, contrasting sharply with the Sensex's modest rise."
      },
      {
        "title": "Strides Pharma Shows Mixed Technical Indicators Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-sciences-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-price-decline-1637093",
        "imagepath": "",
        "date": "2025-03-28 08:02:25",
        "description": "Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 655.90, having closed at 677.50 previously. Over the past year, Strides Pharma has demonstrated a notable return of 76.53%, significantly outperforming the Sensex, which recorded a return of 6.32% during the same period. \n\nIn terms of technical indicators, the company shows a mixed picture. The Moving Averages indicate a bullish stance on a daily basis, while the MACD presents a mildly bearish trend on a weekly basis but remains bullish on a monthly scale. The Bollinger Bands and KST also reflect contrasting signals, with weekly indicators leaning bearish and monthly indicators showing bullish tendencies. \n\nStrides Pharma's performance over longer periods is particularly impressive, with a remarkable 343.38% re..."
      },
      {
        "title": "Strides Pharma Shows Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-sciences-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-strong-performance-1572990",
        "imagepath": "",
        "date": "2025-03-24 08:01:35",
        "description": "Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 702.65, showing a notable increase from the previous close of 666.00. Over the past year, Strides Pharma has demonstrated impressive performance, with a stock return of 93.19%, significantly outperforming the Sensex, which returned 5.87% in the same period.\n\nThe technical summary indicates a mixed outlook across various indicators. While the MACD shows a mildly bearish trend on a weekly basis, it is bullish on a monthly scale. The Bollinger Bands and daily moving averages suggest a positive momentum, contributing to the overall evaluation adjustment. However, the KST and OBV indicators present a more cautious view on a weekly basis.\n\nIn terms of stock performance, Strides Pharma has consistently outperformed th..."
      },
      {
        "title": "Strides Pharma Science Shows Strong Performance Amidst Market Fluctuations and Recovery",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-surges-6-01-outperforming-sector-and-sensex-on-march-21-1554957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/StridesPharmaSc_priceRelatedfactors_767440.png",
        "date": "2025-03-21 15:15:24",
        "description": "Strides Pharma Science has demonstrated strong performance, gaining 6.01% on March 21, 2025, and outperforming its sector. The stock has shown consistent upward movement over the past five days, with significant annual and three-year returns, while the broader market also experienced a recovery."
      },
      {
        "title": "Strides Pharma Science Shows Strong Performance Amid Positive Midcap Pharmaceutical Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-stock-rises-5-18-outperforming-sector-on-march-18-2025-2-1427946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/StridesPharmaSc_priceRelatedfactors_689925.png",
        "date": "2025-03-18 12:35:18",
        "description": "Strides Pharma Science has experienced significant activity, outperforming its sector and showing a cumulative return over recent days. The stock reached an intraday high and is currently above certain moving averages. Over the past year, it has demonstrated remarkable growth compared to broader market indices, reflecting its competitive position."
      },
      {
        "title": "Strides Pharma Science Faces Short-Term Challenges Amidst Market Volatility in February 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-stock-declines-5-37-on-february-14-2025-1009031",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/StridesPharmaSc_priceRelatedfactors_441189.png",
        "date": "2025-02-14 10:05:18",
        "description": "Strides Pharma Science saw a significant decline on February 14, 2025, underperforming its sector. While the stock remains above its 200-day moving average, it trades below several shorter-term averages, indicating recent volatility. Over the past month, it has gained modestly, contrasting with the broader market's slight decline."
      },
      {
        "title": "Strides Pharma Science Faces Mixed Performance Amid Broader Market Trends in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-stock-opens-down-5-68-underperforms-sector-amid-mixed-trends-in-october-2023-1008239",
        "imagepath": "",
        "date": "2025-02-14 09:35:08",
        "description": "Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, opening with a loss of 5.68%. The stock's performance has underperformed its sector by 3.51%, reflecting broader market trends. Throughout the trading session, Strides Pharma Science reached an intraday low of Rs 642.5, marking a decline of 5.68% from the previous close.\n\nIn terms of moving averages, the stock is currently positioned higher than its 20-day and 200-day moving averages, yet it remains below the 5-day, 50-day, and 100-day moving averages. This indicates a mixed short-term performance relative to longer-term trends.\n\nOver the past month, Strides Pharma Science has shown a positive performance of 4.01%, contrasting with the Sensex, which has declined by 0.48%. However, in the short term, the stock's one-day performance reflects a decrease of 3.76%, while the Sensex remaine..."
      },
      {
        "title": "Strides Pharma Science Shows Strong Rebound Amid Market Fluctuations in February 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-stock-gains-5-83-on-february-13-2025-outperforming-sector-998262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/StridesPharmaSc_priceRelatedfactors_429732.png",
        "date": "2025-02-13 12:05:16",
        "description": "Strides Pharma Science experienced a notable rebound on February 13, 2025, reversing a three-day decline with a significant stock increase. The company's performance surpassed the broader sector, and it has shown strong gains over the past month, reflecting resilience in a fluctuating market environment."
      },
      {
        "title": "Strides Pharma Science Faces Continued Decline Amid Mixed Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-stock-declines-5-04-amid-sector-underperformance-on-february-11-2025-3-983672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/StridesPharmaSc_priceRelatedfactors_408045.png",
        "date": "2025-02-11 13:15:24",
        "description": "Strides Pharma Science's stock has declined for two consecutive days, resulting in a total drop of 7.61%. Despite this recent downturn, the stock has gained 6.06% over the past month, outperforming the broader market. Its technical indicators show a mixed performance relative to various moving averages."
      }
    ],
    "total": 192,
    "sid": "688428",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Intimation For Change In Details Of Key Managerial Personnel For Determining Materiality Of Events Or Information And Making Disclosure To Stock Exchange Under Regulation 30 Of SEBI Listing Regulations",
      "datetime": "03-Apr-2025",
      "details": "Intimation for change in details of Key Managerial Personnel for determining materiality of events or information and making disclosure to Stock Exchanges under Regulation 30 of SEBI Listing Regulations effective April 5 2025",
      "source": "BSE"
    },
    {
      "caption": "Update On Redemption Of Secured Unlisted Redeemable Non-Convertible Debentures",
      "datetime": "01-Apr-2025",
      "details": "Redemption of balance outstanding NCDs of Rs. 24.20 Crores.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "21-Mar-2025",
      "details": "Results along with Scrutinizers report for Postal Ballot process.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>25%</strong> dividend, ex-date: 09 Sep 24",
          "dt": "2024-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Strides Pharma Science Outperforms Sector Amid Broader Market Volatility

2025-04-03 09:35:20

Strides Pharma Science has demonstrated strong performance, gaining 6.57% on April 3, 2025, and outperforming its sector. The stock has shown a notable upward trend over the past four days, with a significant annual increase of 78.60%, contrasting sharply with the Sensex's modest rise.

Read More

Strides Pharma Shows Mixed Technical Indicators Amid Strong Long-Term Performance

2025-03-28 08:02:25

Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 655.90, having closed at 677.50 previously. Over the past year, Strides Pharma has demonstrated a notable return of 76.53%, significantly outperforming the Sensex, which recorded a return of 6.32% during the same period. In terms of technical indicators, the company shows a mixed picture. The Moving Averages indicate a bullish stance on a daily basis, while the MACD presents a mildly bearish trend on a weekly basis but remains bullish on a monthly scale. The Bollinger Bands and KST also reflect contrasting signals, with weekly indicators leaning bearish and monthly indicators showing bullish tendencies. Strides Pharma's performance over longer periods is particularly impressive, with a remarkable 343.38% re...

Read More

Strides Pharma Shows Mixed Technical Trends Amid Strong Long-Term Performance

2025-03-24 08:01:35

Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 702.65, showing a notable increase from the previous close of 666.00. Over the past year, Strides Pharma has demonstrated impressive performance, with a stock return of 93.19%, significantly outperforming the Sensex, which returned 5.87% in the same period. The technical summary indicates a mixed outlook across various indicators. While the MACD shows a mildly bearish trend on a weekly basis, it is bullish on a monthly scale. The Bollinger Bands and daily moving averages suggest a positive momentum, contributing to the overall evaluation adjustment. However, the KST and OBV indicators present a more cautious view on a weekly basis. In terms of stock performance, Strides Pharma has consistently outperformed th...

Read More

Strides Pharma Science Shows Strong Performance Amidst Market Fluctuations and Recovery

2025-03-21 15:15:24

Strides Pharma Science has demonstrated strong performance, gaining 6.01% on March 21, 2025, and outperforming its sector. The stock has shown consistent upward movement over the past five days, with significant annual and three-year returns, while the broader market also experienced a recovery.

Read More

Strides Pharma Science Shows Strong Performance Amid Positive Midcap Pharmaceutical Trends

2025-03-18 12:35:18

Strides Pharma Science has experienced significant activity, outperforming its sector and showing a cumulative return over recent days. The stock reached an intraday high and is currently above certain moving averages. Over the past year, it has demonstrated remarkable growth compared to broader market indices, reflecting its competitive position.

Read More

Strides Pharma Science Faces Short-Term Challenges Amidst Market Volatility in February 2025

2025-02-14 10:05:18

Strides Pharma Science saw a significant decline on February 14, 2025, underperforming its sector. While the stock remains above its 200-day moving average, it trades below several shorter-term averages, indicating recent volatility. Over the past month, it has gained modestly, contrasting with the broader market's slight decline.

Read More

Strides Pharma Science Faces Mixed Performance Amid Broader Market Trends in October 2023

2025-02-14 09:35:08

Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, opening with a loss of 5.68%. The stock's performance has underperformed its sector by 3.51%, reflecting broader market trends. Throughout the trading session, Strides Pharma Science reached an intraday low of Rs 642.5, marking a decline of 5.68% from the previous close. In terms of moving averages, the stock is currently positioned higher than its 20-day and 200-day moving averages, yet it remains below the 5-day, 50-day, and 100-day moving averages. This indicates a mixed short-term performance relative to longer-term trends. Over the past month, Strides Pharma Science has shown a positive performance of 4.01%, contrasting with the Sensex, which has declined by 0.48%. However, in the short term, the stock's one-day performance reflects a decrease of 3.76%, while the Sensex remaine...

Read More

Strides Pharma Science Shows Strong Rebound Amid Market Fluctuations in February 2025

2025-02-13 12:05:16

Strides Pharma Science experienced a notable rebound on February 13, 2025, reversing a three-day decline with a significant stock increase. The company's performance surpassed the broader sector, and it has shown strong gains over the past month, reflecting resilience in a fluctuating market environment.

Read More

Strides Pharma Science Faces Continued Decline Amid Mixed Market Dynamics

2025-02-11 13:15:24

Strides Pharma Science's stock has declined for two consecutive days, resulting in a total drop of 7.61%. Despite this recent downturn, the stock has gained 6.06% over the past month, outperforming the broader market. Its technical indicators show a mixed performance relative to various moving averages.

Read More

View All News